← FDA DRUG APPROVALS

FDA ANDA · ANDA084504

HYDRALAZINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA084504
TYPE
ANDA
ORIGINAL APPROVAL
1976-11-23
LATEST ACTION
1996-07-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE HYDROCHLORIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

1996-07-02Manufacturing (CMC) · Supplement 36AP
1991-08-07Manufacturing (CMC) · Supplement 34AP
1990-11-19Manufacturing (CMC) · Supplement 35AP
1990-06-29Manufacturing (CMC) · Supplement 33AP
1984-04-24Manufacturing (CMC) · Supplement 21AP
1984-04-24Manufacturing (CMC) · Supplement 18AP
1984-04-24Manufacturing (CMC) · Supplement 22AP
1984-04-24Manufacturing (CMC) · Supplement 19AP
1976-11-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →